Davendra Sohal, MD

Dr. Sohal is a board-certified medical oncologist, focusing on the treatment of patients with gastrointestinal cancers, with a special interest in clinical trials of cutting-edge drugs and novel approaches to cancer therapy. He joined the University of Cincinnati in October 2019, where he is a Professor of Medicine. He serves as the Associate Director for Clinical Research at the University of Cincinnati Cancer Center, co-leads the GI Cancers Center of Excellence, and is the Director of Experimental Therapeutics. In these roles, his focus is on expanding the clinical trials portfolio in GI cancers, early-phase studies, and precision oncology.

Dr. Sohal earned his medical degree from the All India Institute of Medical Sciences in New Delhi, India. He completed residency training and a year as a Chief Resident in Internal Medicine at the Jacobi Medical Center of the Albert Einstein College of Medicine in Bronx, NY. He then completed a fellowship in Hematology/Oncology at the University of Pennsylvania in Philadelphia, PA. Dr. Sohal has also completed graduate training in epidemiology and biostatistics at the University of Alabama at Birmingham.

Dr. Sohal is the principal investigator of several clinical trials for patients, both in GI cancers and genomics, including national cooperative group, investigator-initiated, and industry-sponsored studies. He is funded by several grants, from Federal, foundation, and pharmaceutical sponsors. His key accolades include an American Society of Clinical Oncology (ASCO) Young Investigator Award, being Chair of the American Board of Internal Medicine (ABIM) Medical Oncology Self-Assessment Committee, the Co-Chair of the American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines Panel for Metastatic Pancreatic Cancer, Co-Chair of the SWOG Pancreas Subcommittee, an Investigator of the Pancreas Task Force of the Gastrointestinal Steering Committee of the National Cancer Institute, and serving on the Editorial Board of JCO Precision Oncology.